Affiliation:
1. Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Moga-142001 Punjab, India
Abstract
Traumatic Brain Injury (TBI) is attributed to a forceful impact on the brain caused by
sharp, penetrating bodies, like bullets and any sharp object. Some popular instances like falls, traffic
accidents, physical assaults, and athletic injuries frequently cause TBI. TBI is the primary cause of
both mortality and disability among young children and adults. Several individuals experience psychiatric
problems, including cognitive dysfunction, depression, post-traumatic stress disorder, and
anxiety, after primary injury. Behavioral changes post TBI include cognitive deficits and emotional
instability (anxiety, depression, and post-traumatic stress disorder). These alterations are linked to
neuroinflammatory processes. On the other hand, the direct impact mitigates inflammation insult by
the release of pro-inflammatory cytokines, namely IL-1β, IL-6, and TNF-α, exacerbating neuronal
injury and contributing to neurodegeneration. During the excitotoxic phase, activation of glutamate
subunits like NMDA enhances the influx of Ca2+ and leads to mitochondrial metabolic impairment
and calpain-mediated cytoskeletal disassembly. TBI pathological insult is also linked to transcriptional
response suppression Nrf-2, which plays a critical role against TBI-induced oxidative stress.
Activation of NRF-2 enhances the expression of anti-oxidant enzymes, providing neuroprotection.
A possible explanation for the elevated levels of NO is that the stimulation of NMDA receptors by
glutamate leads to the influx of calcium in the postsynaptic region, activating NOS's constitutive
isoforms.
Publisher
Bentham Science Publishers Ltd.